Recent content from Joe Carlson
A label change could expand the market for the device maker's CoreValve Evolut system.
Recalled ICD devices made at Puerto Rico facility had potential electrical flaws.
As a lover of history, Jules Smith also was fascinated with the new, playing a key role in the founding of a first-of-its-kind community in…
Developed at the U, the jaw-fixation system uses less-invasive zip-ties that can be removed quickly and without surgery
Industry, officials work to boost security of medical devices.
The St. Paul firm is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.
Sales of Augmenix's SpaceOAR hydrogel are projected to nearly double in the next year.
The nonprofit will focus on older drugs that have become scarce and pricey.
The State Fair broke an all-time attendance record Saturday, with 270,426 people walking through its gates. Sunday's attendance figure wasn't immediately available, but by Monday, the fair could easily meet or even break its overall attendance record and hit the 2 million mark.
As liver diseases grow, the noninvasive scan provides an alternative to a biopsy.
Class action's plaintiffs say executives knew $50 billion deal would cost shareholders.
Plymouth-based medical technology startup Urotronic has raised $20 million in its effort to invent a better way to treat urethral problems.A joint venture of Hillhouse…
By injecting money early in the game, they hope to groom the next big product.
Medtronic's popular medical devices power strong quarterly results.
Devices can reset heart rhythms without using wires in the heart.
IRS officials say the company has shifted income on paper to lower its tax bill.
Critics say company has been slow to act on medical devices' cybersecurity vulnerabilities.
The device, to be made by St. Paul-based Minnetronix, gives doctors a clearer view of how a heart surgery is going.
Takeda hopes to begin making its Entyvio drug for bowel diseases at its Brooklyn Park plant next year
Hackers a persistent threat to patient safety, demanding vigilance.
Focus is on long-term value, cost of pumps and monitors.
Company maintained its financial guidance for year.
The device maker denies the allegations made against Infuse product.
California firm makes device that aims to reduce post-operation strokes.
Strong growth for its diabetes unit was key to driving second quarter earnings that exceeded expectations.
About 39,000 defibrillators and pacemakers are affected by what regulators have classified as a Class 2 recall.
Early study results of 6,000 diabetic patients showed a drop in hospital visits.
Media blitz aims to boost support for a repeal.
Abbott advises patients to get updates at next scheduled doctor visit.
Following tumult in the 1960s and '70s, Bob's sobriety in the 1980s became an example for others.
The California company is developing a treatment for atrial fibrillation.
CEO is setting up shop in Twin Cities, looking to grab part of $20 billion market.
Mpls.-based firm pursuing Boston company's biopsy-free cancer detection tech.
They both focus on round-the-clock monitoring of blood-sugar levels.
Vital Minn. industry sees potential for higher costs, job cuts if tariffs escalate.
Medibio, which has its U.S. headquarters in Savage, is developing apps to diagnose mental-health problems.
A report of a takeover bid by Stryker med-tech firm pushed shares way up.
They vow to appeal company's victory in key Bair Hugger case.
Executives see mix of innovation, lean manufacturing to hit 4 percent annual growth target.
After a design change, Medtronic device reports some initial success.
A power-switching problem can be deadly, according to FDA notice.
NONFICTION: A Wall Street Journal reporter exposes lies at health care company Theranos.
Outcome could affect thousands of other cases that involve the device.
Bair Hugger alleged to contribute to infection; 3M lawyers disagreed.
Strong sales of next-generation insulin pumps for diabetes helped Medtronic PLC surpass investors’ expectations for its latest quarterly results, sending the company’s stock up 2…
"Renal denervation" uses radio-frequency energy in arteries.
The Bair Hugger, a widely used patient warming system from 3M Co., takes center stage in a federal trial scheduled to begin Monday that could affect thousands of patients who came down with serious joint infections after surgery.
Gillette Children's strives for a perfect fit in creating custom devices for young patients.
The company believes Michael Weinstein will bring a new perspective to company's strategies.
The company raised $108 million in its initial public offering, the second biggest for Minnesota in the past year.
The work that Medtronic is doing today stems directly from its co-founder's bold thinking in business and pacemaker engineering, Omar Ishrak says.
Cybersecurity experts look for best practices to thwart unauthorized access.
Company said it plans to resolve lawsuits, IRS disputes later this year.
Columbia Heights is an inner-ring suburban city of 20,158 people at the southernmost tip of Anoka County. The Heights has been a city for 96…
The company hopes that showing the device is effective in treating urethral strictures will lead to FDA approval.
Concern over organic sales growth sends the shares down in early trading
Medtronic CEO touts continual investment in innovation.
The $275M deal gives the device maker products to aid women's health.
Modern health care is pushing makers to think about reimbursement as part of the creation process.
Firm touts $10B market for its sleep apnea device.
Medtronic aims to lower hypertension with procedure, not drugs.
Amplifon will move its U.S. offices from Plymouth to the Fifth Street Towers.
Dr. Laura Mauri will start to transition into the new job in June, and will fully assume the role on Sept. 1.
Ferring says it plans few changes at flourishing Roseville company
Respiratory medical device maker Vyaire Medical plans to close its plant in Plymouth by June 30, eliminating approximately 50 jobs, according to state officials.
Researchers found that a surprising number of the earliest studies on treatments for chronic conditions presented exaggerated results.
Dead patient's mom wins rare appeal in suit over Medtronic's drug pump.
The system creates cardiac maps that can help guide procedures.
Regulators say Monteris hasn't sufficiently addressed safety concerns raised last year.
Potential $406M deal includes NxThera's promising and novel prostate treatment system, Rezum.
Inspector general's report said $4.4M should have been sent to Medicare.
FDA said products could contain undeclared latex, resulting in an unintended allergic reaction.
The Minnetonka medical device maker will keep its ties to state as part of Canada's Laborie Medical Technology.
HeartMate 3 performed better in clinical test than Abbott's older device.
Companies say patients not in danger while pledging vigilance.
More from Star Tribune